Outlook Therapeutics Strengthens Medical Affairs and Commercial Expertise with Appointments of Surendra Sharma, MD, Senior Vice President of Medical Affairs and Glen Olsheim, Executive Director of Commercial Excellence
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company developing and launching the first FDA-cleared ophthalmic formulation of bevacizumab for use in retinal indications, today announced […]